NISA INVESTMENT ADVISORS, LLC - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 152 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,099
-44.1%
546
+7.1%
0.00%
Q2 2023$10,914
+155814.3%
510
+188.1%
0.00%
Q1 2023$7
-83.7%
177
-80.9%
0.00%
Q4 2022$43
-99.9%
927
-1.0%
0.00%
Q3 2022$42,000
-26.3%
936
-22.5%
0.00%
Q2 2022$57,000
+72.7%
1,207
+164.1%
0.00%
Q1 2022$33,000
-63.7%
457
-70.2%
0.00%
-100.0%
Q4 2021$91,000
-63.7%
1,534
-65.3%
0.00%
-50.0%
Q3 2021$251,000
-11.3%
4,420
-31.3%
0.00%0.0%
Q2 2021$283,000
-10.7%
6,4340.0%0.00%0.0%
Q1 2021$317,000
+17.0%
6,4340.0%0.00%0.0%
Q4 2020$271,000
+61.3%
6,434
+75.2%
0.00%
+100.0%
Q3 2020$168,000
+425.0%
3,672
+473.8%
0.00%
Q2 2020$32,000
+357.1%
640
+357.1%
0.00%
Q1 2020$7,000
+16.7%
140
+55.6%
0.00%
Q4 2019$6,000
+20.0%
900.0%0.00%
Q3 2019$5,000
-37.5%
900.0%0.00%
Q2 2019$8,000
-11.1%
900.0%0.00%
Q1 2019$9,000
+50.0%
900.0%0.00%
Q4 2018$6,000
-25.0%
900.0%0.00%
Q3 2018$8,000900.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 858,811$36,156,00010.56%
Fairmount Funds Management LLC 150,433$6,333,0002.26%
ARMISTICE CAPITAL, LLC 1,356,000$57,088,0001.94%
FARALLON CAPITAL MANAGEMENT LLC 1,775,000$74,728,0000.45%
Virtus ETF Advisers LLC 14,321$603,0000.25%
Granahan Investment Management 231,071$9,728,0000.22%
JACOBS LEVY EQUITY MANAGEMENT, INC 248,320$10,454,0000.09%
ACADIAN ASSET MANAGEMENT LLC 467,514$19,684,0000.08%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 126$5,0000.08%
AIGEN INVESTMENT MANAGEMENT, LP 12,854$541,0000.07%
View complete list of ENANTA PHARMACEUTICALS INC shareholders